- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 487/04 - Ortho-condensed systems
Patent holdings for IPC class C07D 487/04
Total number of patents in this class: 23341
10-year publication summary
|
1484
|
1578
|
1654
|
1781
|
1670
|
1758
|
1937
|
1797
|
1641
|
815
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4721 |
478 |
| F. Hoffmann-La Roche AG | 7832 |
368 |
| Hoffmann-La Roche Inc. | 3773 |
323 |
| Merck Sharp & Dohme LLC | 3728 |
317 |
| Novartis AG | 10300 |
309 |
| Janssen Pharmaceutica N.V. | 3177 |
308 |
| Gilead Sciences, Inc. | 2219 |
304 |
| Incyte Corporation | 1068 |
280 |
| Merck Patent GmbH | 5725 |
274 |
| Boehringer Ingelheim International GmbH | 4501 |
242 |
| Genentech, Inc. | 4101 |
214 |
| Dana-Farber Cancer Institute, Inc. | 2657 |
194 |
| Pfizer Inc. | 3384 |
193 |
| Takeda Pharmaceutical Company Limited | 2714 |
183 |
| AstraZeneca AB | 2815 |
154 |
| Incyte Holdings Corporation | 626 |
152 |
| Abbvie Inc. | 1838 |
126 |
| The Regents of the University of California | 20690 |
118 |
| Amgen Inc. | 4425 |
118 |
| LG Chem, Ltd. | 17929 |
115 |
| Other owners | 18571 |